The office, people and counterparty names on this page are hidden. Create a free account to reveal 5 records a month, or get Family Office Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
M•••••• C•••••• P•••••••
Single family office (probable).
Composed from this office's classification, location and record.
- Decision makers
- 1 of 1
Nothing material in the last 365 days. Last change: 14 Sep 2026, ••• Locked.
Readings, classification basis and verificationidentity confidence 70% · 21 observations · 3 sourcesShowHide
Why this class: a filing by a third party describes it as a single family office (cited).
Each reading is 0 to 100 from the listed components in the evidence section; hover a tile for what it measures. No evidence yet of: direct investing, external managers, private markets, sponsor-friendly, real estate, co-investment.
Overviewshow
- Classification
- Single family office (probable)
- Description
- ••• Locked
- Headquarters
- ••• Locked
- Office address
- unknown
- Business phone
- unknown
- Website
- unknown
- Year established
- unknown
- Assets under management
- unknown
- Capital scale
- Reported office AUM: unknown. No public number of any kind.
- Sep 14, 2026Single family office (probable) 70%a filing by a third party describes it as a single family office (cited)Fact
- Sep 14, 2026Candidate 25%no rule matched; held as a candidate pending researchInference
Family and wealth originshow
- Family served
- The M•••••• family; M••• C. M•••••• is the principal and runs the office himself as CIO.
- Source of wealth
- ••• Locked
- Operating company origin
- Prometheus Biosciences, Inc., a clinical-stage biotechnology company the principal led as President, CEO and Chairman.
Team1 people, 1 with investment decisions, decision makers firstshow
| Person | Title | Responsibility | Business contact | Source |
|---|---|---|---|---|
| M••• M•••••• family | Chief Investment Officer and Managing Director | Chief investment officer · investment decisions | none on record | sec.gov Fact |
Signals and timeline3show
Most significant first: what kind of change it is, its size, whose change it is, and how recent. 3 events. 13F position changes are under Public stakes and holdings.
- Jun 17, 2026Office discovered••• LockedDiscoveryFactsec.gov
- Sep 14, 2026Classification changed••• Lockedc•••••••••Factno URL
- Aug 11, 2023Office formed••• LockedOrganisationFactbizprofile.net
Investment mandateshow
- Invests directly
- Invests directly in therapeutics companies rather than allocating to managers; the office describes itself as investing in treatments, not in funds.
- Allocates to managers
- unknown
- Asset classes
- unknown
- Sectors
- Life sciences only: therapeutics for debilitating and immune-mediated diseases. The mandate as stated carries no other sector.
- Geography
- unknown
- Check size
- unknown
Direct investmentsshow
Fund and manager relationshipsshow
Public stakes and holdingsshow
Real estateshow
Co-investorsshow
Independent sponsor relationshipsshow
Related entities1show
Sources and evidence21show
Every observation behind this profile: the value, when it was effective, the source, the quote where there is one, and whether it is a fact, an inference or an estimate. 21 shown.
Score components
View all 21 observationsShow fewer
| Fact | Value | Effective | Source | Class |
|---|---|---|---|---|
| Board participation | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Decision rights | ••• Locked “••• Locked” | Aug 11, 2023 | DFX analyst research (General-assisted, every claim URL-cited) bizprofile.net | Fact |
| Description | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Edgar fts discovery | family office | Jun 17, 2026 | SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.gov | Fact |
| Family generation | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Family involvement | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Family served | M•••••• family “••• Locked” | n/a | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Family served | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Formation year | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Headquarters | ••• Locked “••• Locked” | Aug 11, 2023 | DFX analyst research (General-assisted, every claim URL-cited) bizprofile.net | Fact |
| Invests directly | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Legal entity | ••• Locked “M•••••• C•••••• P••••••• LLC” | Aug 11, 2023 | DFX analyst research (General-assisted, every claim URL-cited) bizprofile.net | Fact |
| Liquidity event | ••• Locked “••• Locked” | Jun 30, 2023 | DFX analyst research (General-assisted, every claim URL-cited) apogeetherapeutics.com | Fact |
| Office type (stated) | Single family office | Jun 17, 2026 | SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.gov | Fact |
| Operating company origin | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Sectors | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Stage preference | ••• Locked “••• Locked” | Sep 21, 2026 | DFX analyst research (General-assisted, every claim URL-cited) apogeetherapeutics.com | Inference |
| Team size total | ••• Locked “••• Locked” | Aug 11, 2023 | DFX analyst research (General-assisted, every claim URL-cited) bizprofile.net | Estimate |
| Source of wealth | ••• Locked “••• Locked” | Apr 1, 2024 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Website search | Not found | Sep 16, 2026 | DFX model output (c••••••••• rules, scores, mandates, matches) no URL | Inference |
| Website search | Not found | Sep 14, 2026 | DFX model output (c••••••••• rules, scores, mandates, matches) no URL | Inference |
Not yet on record: direct investments, capital scale, last deployment.